Edition:
United Kingdom

Tetraphase Pharmaceuticals Inc (TTPH.O)

TTPH.O on Nasdaq

0.40USD
19 Jul 2019
Change (% chg)

$-0.01 (-2.93%)
Prev Close
$0.41
Open
$0.43
Day's High
$0.43
Day's Low
$0.40
Volume
347,811
Avg. Vol
617,081
52-wk High
$3.66
52-wk Low
$0.40

About

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections. The Company is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous (IV) and oral... (more)

Overall

Beta: 2.27
Market Cap(Mil.): $21.73
Shares Outstanding(Mil.): 54.26
Dividend: --
Yield (%): --

Financials

  TTPH.O Industry Sector
P/E (TTM): -- 30.63 34.52
EPS (TTM): -1.32 -- --
ROI: -67.30 13.02 12.69
ROE: -80.10 14.18 17.17

Earnings vs. Estimates